The innermost layer of the heart is the endothelium
Endotheliumlining the cardiac chambers is continuous with the endothelium of all blood vessels in the body and is composed of squamous epithelial cells
The cardiac endothelium provides a friction free interface between the walls of the chambers and the blood contained within them and moving through them
This layer just like endothelial cells lining blood vessels also secretes prostacyclin, which repelsplatelets and prevents platelet adhesion to the walls of the cardiac chambers and vessels
Why is it important to stop platelets forming within the cardiac chambers and vessels?
Preventing Blood Clots (Thrombosis)
Platelets play a vital role in blood clot formation, but if they aggregate unnecessarily inside heart or vessels, thrombi (clots) that obstruct blood flow can form
Reducing the Risk of Stroke and Embolism
If a thrombus forms in the left atrium/ventricle, it can break off and go to the brain, causing an ischemic stroke.
This is dangerous in conditions like atrial fibrillation, where irregular heartbeats can lead to blood pooling in the atria, increasingclot risk
Why is it important to stop platelets forming within the cardiac chambers and vessels?
Preventing Heart Attacks (Myocardial Infarction)
Platelet aggregation in the coronary arteries can block blood supply to the heart muscle, leading to a heart attack (myocardial infarction)
This occurs when a plaque ruptures in coronary artery disease, triggering platelet activation and clot formation
Avoiding Pulmonary Embolism
thrombus in the right atrium or right ventricle can travel to the lungs, causing a pulmonary embolism
This can impair oxygen exchange, leading to respiratory failure and death
Why is it important to stop platelets forming within the cardiac chambers and vessels?
Maintaining Healthy Circulation
Platelet overactivity can lead to hypercoagulability, increasing the risk of widespread clotting (e.g., deep vein thrombosis (DVT) or disseminated intravascular coagulation (DIC)).
Antiplatelet medications (e.g., aspirin, clopidogrel) and anticoagulants (e.g., warfarin, heparin) are often prescribed to prevent clot formation in high-risk individuals.